972 related articles for article (PubMed ID: 22214754)
41. Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries.
Graham PL; Moran JL
J Clin Epidemiol; 2012 May; 65(5):503-10. PubMed ID: 22265586
[TBL] [Abstract][Full Text] [Related]
42. Trial Registry Use in Surgery Systematic Reviews: A Cross-Sectional Study.
Gray HM; Simpson A; Bowers A; Johnson AL; Vassar M
J Surg Res; 2020 Mar; 247():323-331. PubMed ID: 31708197
[TBL] [Abstract][Full Text] [Related]
43. Research Techniques Made Simple: Workflow for Searching Databases to Reduce Evidence Selection Bias in Systematic Reviews.
Le Cleach L; Doney E; Katz KA; Williams HC; Trinquart L
J Invest Dermatol; 2016 Dec; 136(12):e125-e129. PubMed ID: 27884295
[TBL] [Abstract][Full Text] [Related]
44. Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project.
Amarilyo G; Furst DE; Woo JM; Li W; Bliddal H; Christensen R; Tarp S
PLoS One; 2016; 11(1):e0147556. PubMed ID: 26808309
[TBL] [Abstract][Full Text] [Related]
45. Grey literature in systematic reviews: a cross-sectional study of the contribution of non-English reports, unpublished studies and dissertations to the results of meta-analyses in child-relevant reviews.
Hartling L; Featherstone R; Nuspl M; Shave K; Dryden DM; Vandermeer B
BMC Med Res Methodol; 2017 Apr; 17(1):64. PubMed ID: 28420349
[TBL] [Abstract][Full Text] [Related]
46. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials.
Ioannidis JP; Trikalinos TA
J Clin Epidemiol; 2005 Jun; 58(6):543-9. PubMed ID: 15878467
[TBL] [Abstract][Full Text] [Related]
47. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
Rising K; Bacchetti P; Bero L
PLoS Med; 2008 Nov; 5(11):e217; discussion e217. PubMed ID: 19067477
[TBL] [Abstract][Full Text] [Related]
48. An empirical comparison of univariate and multivariate meta-analyses for categorical outcomes.
Trikalinos TA; Hoaglin DC; Schmid CH
Stat Med; 2014 Apr; 33(9):1441-59. PubMed ID: 24285290
[TBL] [Abstract][Full Text] [Related]
49. Methodological quality of systematic reviews on influenza vaccination.
Remschmidt C; Wichmann O; Harder T
Vaccine; 2014 Mar; 32(15):1678-84. PubMed ID: 24513008
[TBL] [Abstract][Full Text] [Related]
50. Publication bias in dermatology systematic reviews and meta-analyses.
Atakpo P; Vassar M
J Dermatol Sci; 2016 May; 82(2):69-74. PubMed ID: 26925817
[TBL] [Abstract][Full Text] [Related]
51. US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis.
Razavi M; Glasziou P; Klocksieben FA; Ioannidis JPA; Chalmers I; Djulbegovic B
JAMA Netw Open; 2019 Sep; 2(9):e1911111. PubMed ID: 31509209
[TBL] [Abstract][Full Text] [Related]
52. Ratio of geometric means to analyze continuous outcomes in meta-analysis: comparison to mean differences and ratio of arithmetic means using empiric data and simulation.
Friedrich JO; Adhikari NK; Beyene J
Stat Med; 2012 Jul; 31(17):1857-86. PubMed ID: 22438170
[TBL] [Abstract][Full Text] [Related]
53. Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study.
Wallach JD; Ciani O; Pease AM; Gonsalves GS; Krumholz HM; Taylor RS; Ross JS
BMC Med; 2018 Mar; 16(1):45. PubMed ID: 29562926
[TBL] [Abstract][Full Text] [Related]
54. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
[TBL] [Abstract][Full Text] [Related]
55. Grey literature in meta-analyses of randomized trials of health care interventions.
Hopewell S; McDonald S; Clarke M; Egger M
Cochrane Database Syst Rev; 2007 Apr; 2007(2):MR000010. PubMed ID: 17443631
[TBL] [Abstract][Full Text] [Related]
56. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.
Chan AW; Krleza-Jerić K; Schmid I; Altman DG
CMAJ; 2004 Sep; 171(7):735-40. PubMed ID: 15451835
[TBL] [Abstract][Full Text] [Related]
57. Researcher allegiance in psychotherapy outcome research: an overview of reviews.
Munder T; Brütsch O; Leonhart R; Gerger H; Barth J
Clin Psychol Rev; 2013 Jun; 33(4):501-11. PubMed ID: 23500154
[TBL] [Abstract][Full Text] [Related]
58. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
Chan AW; Hróbjartsson A; Haahr MT; Gøtzsche PC; Altman DG
JAMA; 2004 May; 291(20):2457-65. PubMed ID: 15161896
[TBL] [Abstract][Full Text] [Related]
59. [Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence].
Purgato M; Cipriani A; Barbui C
Riv Psichiatr; 2012; 47(1):21-9. PubMed ID: 22358214
[TBL] [Abstract][Full Text] [Related]
60. Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses.
Baudard M; Yavchitz A; Ravaud P; Perrodeau E; Boutron I
BMJ; 2017 Feb; 356():j448. PubMed ID: 28213479
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
